Good to the last drop.
Tumor genetic analysis is the standard of care in the management of gastrointestinal stromal tumor (GIST). And what’s better than a throat scope and biopsy? A finger prick. This retrospective analysis of 243 patients with GIST undergoing serum circulating tumor DNA sequencing in addition to standard tissue sequencing demonstrates a positive predictive value of 100% for the serum test to detect pathogenic mutations. | Arshad, J Clin Oncol 2020
Comments
Post a Comment